Pharma Deal Watch: The Angelini family’s U.S. expansion plans are getting concrete after Angelini Pharma targeted Catalyst Pharmaceuticals in Florida, signaling a bigger push for rare-disease innovation beyond Europe. AI for Clinical Trials: NetraMark says it’s expanding adoption of its NetraAI platform, including a first commercial project via CRO partners, as it builds its clinical-development footprint. Biotech Pipeline Update: NovaBridge reported first-half 2026 results and leadership changes, with givastomig moving toward a potential Phase 3 push and VIS-101 progressing toward Phase 2b. Frontier Tech in Rome: AIBC World 2026 kicks off its countdown in Rome, aiming to draw 30,000 delegates and 1,000 exhibitors around AI, blockchain, fintech and digital innovation. OpenAI Ads Go EU (Italy included): OpenAI will start serving ChatGPT ads in 31 European markets on Aug. 24, including Italy, with buying routed through major ad networks. SMB Tech Reality Check: A new FCC move in the U.S. tightens rules on foreign advanced robots, a reminder for startups that hardware supply chains can get hit fast. Fashion Tech for Retail: Turin startup Ustyle is scaling “complete outfit” personalization for e-commerce from a single catalog, targeting higher conversion and order value. Sustainable Tourism (Italy-linked): Italy-backed “Via delle Cascate” in Bosnia is upgrading trails and tourism access, involving local businesses and communities.